These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37625583)

  • 21. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
    Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
    Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
    Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
    Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.
    Cochrane DE; Carraway RE; Harrington K; Laudano M; Rawlings S; Feldberg RS
    Inflamm Res; 2011 Dec; 60(12):1139-51. PubMed ID: 21927981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3.
    Richard F; Barroso S; Nicolas-Ethève D; Kitabgi P; Labbé-Jullié C
    Eur J Pharmacol; 2001 Dec; 433(1):63-71. PubMed ID: 11755135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
    Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
    J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn.
    Kadiri N; Rodeau JL; Schlichter R; Hugel S
    Eur J Neurosci; 2011 Oct; 34(8):1230-40. PubMed ID: 21936876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin receptor 1 facilitates intracellular and transepithelial delivery of macromolecules.
    Bird JL; Simpson R; Vllasaliu D; Goddard AD
    Eur J Pharm Biopharm; 2017 Oct; 119():300-309. PubMed ID: 28690201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
    Kitabgi P
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between neurotensin receptors and G proteins.
    Pelaprat D
    Peptides; 2006 Oct; 27(10):2476-87. PubMed ID: 16919370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based evolution of subtype-selective neurotensin receptor ligands.
    Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
    ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data set describing the
    Besserer-Offroy É; Tétreault P; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent A; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
    Data Brief; 2020 Aug; 31():105884. PubMed ID: 32637491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotensin NTS
    Steele FF; Whitehouse SC; Aday JS; Prus AJ
    Brain Res; 2017 Mar; 1658():31-35. PubMed ID: 28089664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis.
    Bossard C; Souazé F; Jarry A; Bezieau S; Mosnier JF; Forgez P; Laboisse CL
    Peptides; 2007 Oct; 28(10):2030-5. PubMed ID: 17870207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of neurotensin receptor type 1 attenuates locomotor activity.
    Vadnie CA; Hinton DJ; Choi S; Choi Y; Ruby CL; Oliveros A; Prieto ML; Park JH; Choi DS
    Neuropharmacology; 2014 Oct; 85():482-92. PubMed ID: 24929110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1.
    Hou T; Shi L; Wang J; Wei L; Qu L; Zhang X; Liang X
    Pharmacol Res; 2016 Jun; 108():39-45. PubMed ID: 27117668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction.
    White JF; Grodnitzky J; Louis JM; Trinh LB; Shiloach J; Gutierrez J; Northup JK; Grisshammer R
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12199-204. PubMed ID: 17620610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
    Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
    Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the interaction between neurotensin receptor NTS1 and Gq protein by lipid.
    Inagaki S; Ghirlando R; White JF; Gvozdenovic-Jeremic J; Northup JK; Grisshammer R
    J Mol Biol; 2012 Mar; 417(1-2):95-111. PubMed ID: 22306739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging role of neurotensin in regulation of the cardiovascular system.
    Osadchii OE
    Eur J Pharmacol; 2015 Sep; 762():184-92. PubMed ID: 26004530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
    Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
    Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.